Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000545378 | SCV000658392 | likely benign | Multiple endocrine neoplasia, type 2 | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256397 | SCV002529916 | likely benign | Hereditary cancer-predisposing syndrome | 2021-08-09 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV000545378 | SCV004827068 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-10-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002256397 | SCV005028221 | likely benign | Hereditary cancer-predisposing syndrome | 2024-02-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |